Find a Physician

Return to Conditions We Treat Overview

More on Conditions We Treat

Research and Clinical Trials

Return to Conditions We Treat Overview

More on Conditions We Treat

For Patients, Families & Visitors

Return to Conditions We Treat Overview

More on Conditions We Treat

Professionals

Return to Conditions We Treat Overview

More on Conditions We Treat

Hospital News

Return to Conditions We Treat Overview

More on Conditions We Treat

Pediatric Hematology/Oncology/Stem Cell Transplantation

Conditions We Treat

Using a multidisciplinary approach, specialists at NewYork-Presbyterian/Morgan Stanley Children's Hospital provide treatment for a wide range of cancers and noncancerous blood disorders, as well as stem cell and bone marrow transplantation for patients who may benefit from these therapies. While we treat all types of cancer and blood disorders, we have special expertise in the treatment of:

  • Hodgkin lymphoma, including patients with high-risk disease. One of our physicians chairs the Children's Oncology Group Hodgkin Lymphoma Committee. Patients may participate in clinical trials of novel treatment approaches.
  • Leukemias, including patients with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and rarer subtypes such as juvenile myelomonocytic leukemia (JMML). Our physicians are leaders in national clinical trials to improve cure rates and reduce the side effects of current treatments.
  • Liver tumors, in collaboration with liver surgeons and hepatologists (medical doctors who specialize in liver disease) in our Center for Liver Disease and Transplantation.
  • Brain and spinal cord tumors -- such as medulloblastoma, glioblastoma, and ependymoma — featuring the expertise of pediatric neurosurgeons and offering clinical trials of new therapies.
  • Sickle cell disease, offering bone marrow transplantation (the only cure for sickle cell disease) and medical treatment and support.
  • Lymphoproliferative disorders (such as Epstein-Barr virus-associated T-cell disorders) in organ transplant patients, offering novel cellular therapies for these diseases.
  • Wilms' tumor, a type of kidney cancer in children. Our investigators are exploring the genetics of this disease and conducting clinical trials of new treatments.

Other conditions we have strong experience treating include:

Cancer (Oncology)

  • Chronic myelogenous leukemia (CML)
  • Non-Hodgkin's lymphoma (NHL)
  • Myelodysplastic syndrome (MDS)
  • Neuroblastoma
  • Histiocytic disorders
  • Rhabdomyosarcoma
  • Ewing sarcoma
  • Retinoblastoma
  • Germ cell tumors
  • Desmoplastic small round cell tumor
  • Osteosarcoma
  • Primitive neuroectodermal tumors (PNET)
  • Atypical teratoid rhabdoid tumor (ATRT)

Non-Cancerous Blood Disorders (Hematology)

  • Thalassemias
  • Iron deficiency and overload anemias
  • Thrombosis and hemostasis
  • Coagulation and platelet disorders
  • Bleeding disorders
  • Vascular anomalies
  • Primary immunodeficiencies
  • Bone marrow failure syndromes

Stem Cell Transplantation

  • Cancer (e.g., ALL, lymphoma, neuroblastoma)
  • Hemoglobin disorders (e.g., sickle cell, thalassemia)
  • Bone marrow failure (e.g., aplastic anemia, MDS)
  • Severe combined immunodeficiency syndrome (SCIDS)
  • Hemophagocytosis lymphohistiocytosis (HLH)
  • Other immunological disorders (e.g., Wiskott-Aldrich syndrome)
  • Metabolic disorders (e.g., adrenal leukodystrophy)

Contact

Division of Pediatric Hematology/Oncology/Stem Cell Transplantation
(212) 305-5808
  • Bookmark
  • Print




Top of page